Labrini Papanastasiou Selected Research

Hypertension (High Blood Pressure)

12/2022	Pre- and peri-operative characteristics, complications and outcomes of patients with biochemically silent pheochromocytomas; a case series.
1/2022	Enhanced performance of a modified diagnostic test of primary aldosteronism in patients with adrenal adenomas.
1/2022	Juxtaglomerular cell tumour of the kidney: a rare cause of resistant hypertension.
10/2017	Surgery for pheochromocytoma: A 20-year experience of a single institution.
7/2016	A new highly sensitive and specific overnight combined screening and diagnostic test for primary aldosteronism.
8/2015	Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension.
5/2015	Progress in aldosteronism: a review of the prevalence of primary aldosteronism in pre-hypertension and hypertension.
4/2013	Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension.
4/2012	Pattern of adrenal hormonal secretion in patients with adrenal adenomas: the relevance of aldosterone in arterial hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Labrini Papanastasiou Research Topics

Disease

9	Hypertension (High Blood Pressure) 12/2022 - 04/2012
7	Hyperaldosteronism (Conn Syndrome) 06/2020 - 04/2013
4	Adenoma (Adenomas) 01/2017 - 04/2012
3	Neoplasms (Cancer) 12/2022 - 04/2014
3	Pheochromocytoma 12/2022 - 11/2012
3	Essential Hypertension 09/2022 - 05/2015
2	Non-alcoholic Fatty Liver Disease 06/2017 - 11/2012
2	Infections 04/2016 - 10/2012
1	Hypotension (Low Blood Pressure) 12/2022
1	Takotsubo Cardiomyopathy 12/2022
1	Lymphoma (Lymphomas) 01/2022
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 06/2021
1	Ketosis 06/2021
1	Acidosis 06/2021
1	Thyroid Neoplasms (Thyroid Cancer) 04/2021
1	Hyperkalemia 06/2020
1	Morbid Obesity 01/2020
1	Vitamin D Deficiency 01/2020
1	Osteomalacia 01/2020
1	Stress Fractures (Stress Fracture) 01/2020
1	Endometriosis 01/2017
1	Female Infertility 01/2017
1	Adrenal incidentaloma 01/2017
1	Autoimmune Hypophysitis 04/2016
1	Diabetes Mellitus 10/2015
1	Hypersensitivity (Allergy) 08/2015
1	Prehypertension 05/2015
1	Hyperplasia 05/2015
1	Insulinoma 04/2015
1	Hypoglycemia (Reactive Hypoglycemia) 04/2015
1	Hyperinsulinism (Hyperinsulinemia) 04/2015
1	Prolactinoma (Prolactinomas) 04/2014
1	Insulin Resistance 11/2012
1	Abdominal Obesity 11/2012
1	Seizures (Absence Seizure) 10/2012
1	Pain (Aches) 11/2011
1	Hypophosphatemia 11/2011
1	Familial Hypophosphatemia (Phosphate Diabetes) 11/2011
1	Muscle Weakness 11/2011
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2010
1	Paralysis (Palsy) 01/2010
1	Hyperthyroidism 01/2010
1	Hypokalemia 01/2010
1	Autoimmune Diseases (Autoimmune Disease) 08/2007

Drug/Important Bio-Agent (IBA)

10	AldosteroneIBA 09/2022 - 04/2012
4	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2017 - 11/2012
3	Adrenocorticotropic Hormone (ACTH)FDA Link 09/2022 - 05/2015
3	ReninIBA 01/2022 - 08/2015
2	PotassiumIBA 01/2022 - 04/2013
2	Glucose (Dextrose)FDA LinkGeneric 06/2021 - 11/2012
2	Mineralocorticoid Receptor AntagonistsIBA 06/2020 - 08/2015
2	GlucocorticoidsIBA 06/2017 - 04/2016
1	Vasodilator Agents (Vasodilators)IBA 12/2022
1	Vasoconstrictor AgentsIBA 12/2022
1	CatecholaminesIBA 12/2022
1	Phenoxybenzamine FDA Link 12/2022
1	Valsartan (Vals)FDA Link 09/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2022
1	Captopril (Capoten)FDA LinkGeneric 09/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022
1	SodiumIBA 06/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 06/2021
1	Tyrosine Kinase InhibitorsIBA 04/2021
1	SaltsIBA 06/2020
1	CalciumIBA 01/2020
1	Ergocalciferols (Ergocalciferol)FDA LinkGeneric 01/2020
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 10/2017
1	EnzymesIBA 06/2017
1	Adrenergic Agents (Adrenergic Drugs)IBA 06/2017
1	AndrogensIBA 06/2017
1	Cortisone FDA Link 06/2017
1	Dehydroepiandrosterone (DHEA)IBA 06/2017
1	Oxidoreductases (Dehydrogenase)IBA 06/2017
1	Vitamin D FDA LinkGeneric 01/2017
1	Azathioprine (Imuran)FDA LinkGeneric 04/2016
1	Blood Glucose (Blood Sugar)IBA 10/2015
1	Insulin (Novolin)FDA Link 10/2015
1	Hormones (Hormone)IBA 04/2015
1	Diazoxide (Hyperstat)FDA Link 04/2015
1	ProlactinIBA 04/2014
1	Cabergoline FDA LinkGeneric 04/2014
1	Dopamine Agonists (Dopamine Agonist)IBA 04/2014
1	Triglycerides (Triacylglycerol)IBA 11/2012
1	Parathyroid Hormone (Parathormone)IBA 11/2011
1	Fibroblast Growth Factor-23IBA 11/2011
1	Cinacalcet (Sensipar)FDA Link 11/2011
1	Calcitriol (Calcijex)FDA LinkGeneric 11/2011
1	Thyroid HormonesIBA 01/2010
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2010
1	AntibodiesIBA 08/2007
1	EpitopesIBA 08/2007
1	IodineIBA 08/2007

Therapy/Procedure

3	Therapeutics 11/2014 - 04/2014
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2020
1	Bariatric Surgery 01/2020
1	Adrenalectomy 10/2017
1	Glycemic Control 10/2015
1	Drug Therapy (Chemotherapy) 10/2012